The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Clinical Study on Jianpi Jiedu Decoction Regulate the Immune Function in Elderly Lung Cancer
Author(s): 
Pages: 150-153
Year: Issue:  5
Journal: Journal of Liaoning College of Traditional Chinese Medicine

Keyword:  lung cancerJianpi Jiedu decoctionprescription;
Abstract: Objective:To observe the effect on lung cancer related symptoms of TCM Recipe plus chemotherapy treatment of patients wish advanced Lung cancer. Methods:62 patients with advanced Lung cancer were randomized divided into 2 groups:chemotherapy and TCM and chemotherapy group. short term effect,survival,to xicity,improvement of symptoms were evaluated after at 8 weeks of treatment. Results:clinical study,there no significant differences between groups 2 response rates and hematological toxicity(P>0.05).observe group had symptomatic improvement,significantly better than control group(P<0.05).Stabilizing rates(CR+PR+NC/N),observe group much better then control group. T cells after treatment observation group(CD3)and NK cells were significantly increased,CD8 cells decreased(P<0.05).Two groups CD4+CD25+Treg cells in CD4+proportion has decreased,the ratio of the observation group than the control group,with significant difference(P<0.05). Conclusion:Clinical studies show that the prescription can be significantly improved patients with cellular immune function,improve symptoms of lung cancer,improve lung cancer rates stable.
Related Articles
No related articles found